SCHEMBL19637404

SCHEMBL19637404

CCCCCOc1nc(C)c(CC)c(N(CC)C(C)CO)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19637079 0.75 HTT (0.32) —
SCHEMBL22994841 0.69 KDM4E (0.38) —
SCHEMBL19637432 0.67 KDM4E (0.36) —
SCHEMBL14141549 0.65 NR5A1 (0.46) —
SCHEMBL899058 0.64 NR5A1 (0.43) —
SCHEMBL19637369 0.63 HTT (0.35) —
SCHEMBL11587263 0.62 NR5A1 (0.47) —
SCHEMBL11009919 0.62 NR5A1 (0.47) —
SCHEMBL25384494 0.62 NR5A1 (0.47) —
SCHEMBL17132049 0.61 NR5A1 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017201161-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2017-11-23 — — WO disclosed
Send feedback